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 12 
The materials community is now identifying polymeric substrates that could permit 13 
translation of human pluripotent stem cells (hPSCs) from lab-based research to 14 
industrial scale biomedicine. Well defined materials are required to allow cell banking 15 
and to provide the raw material for reproducible differentiation into lineages for large 16 
scale drug screening programs and clinical use, wherein >1 billion cells for each 17 
patient are needed to replace losses during heart attack, multiple sclerosis and 18 
diabetes. Producing this number of cells for one patient is challenging and a rethink is 19 
needed to scalable technology with the potential to meet the needs of millions of 20 
patients a year. Here we consider the role of materials discovery, an emerging area of 21 
materials chemistry that is in a large part driven by the challenges posed by biologists 22 
to materials scientists
1-4
. 23 
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Evolution of stem cell culture 1 
 2 
The term human pluripotent stem cells (hPSCs) describes both human embryonic 3 
stem cells (hESCs), typically derived from the inner cell mass of pre-implantation 4 
embryos
5
, and human induced pluripotent stem cells (hiPSCs) derived by epigenetic 5 
reprogramming of somatic cells with stem cell-associated factors
6
. Because hPSCs 6 
can self-renew for months, if not years, in culture and can be induced to differentiate 7 
into all three germ layers, they provide immense potential for regenerative medicine 8 
and drug development, as well as providing new in vitro models of genetic disease
7
. 9 
However, for biomedical applications to be realized, defined culture conditions need 10 
to be established to eliminate batch variability and xenogenic contaminants. 11 
Furthermore, scalable culture systems are required
8-9
. For adherent culture systems, 12 
scalability is often achieved by increasing the surface area of a growth substrate in T-13 
75 flasks (75 cm
2
 growth area) without compromising biological performance as 14 
measured by pluripotency markers. 15 
Compared to a cell derived proteinaceous mixture such as Matrigel
10
, polymers are 16 
reproducible and amenable to large scale manufacture, e.g. injection molding is 17 
currently used to form tens of millions of tissue culture vessels per year. Consequently 18 
there are significant efforts to identify synthetic strategies with the ultimate aim being 19 
an inexpensive polymer that can be used off the shelf without pre- adsorption of 20 
proteins or immobilization of other biomolecules such as peptides. Furthermore, a 21 
fully synthetic growth substrate would be amenable to automated robotic cell culture, 22 
paving the way for stem cell factories manufacturing billions of hPSCs suitable for 23 
clinical use. 24 
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This review describes the development of growth substrates for hPSC culture from 1 
cell extracts to polymeric-derived materials and assesses the cost and scalability 2 
issues associated with the most recent advances in hPSC with a particular focus on 3 
materials discovery. 4 
 5 
 6 
Feeder layers to support hPSC growth 7 
 8 
Over the last 15 years, progress towards more precisely defined culture systems for 9 
hPSCs has been made, summarized in Table 1. Initial reports of hPSC culture 10 
employed feeder layers of mouse embryonic fibroblasts (MEFs) to support the self-11 
renewal of hPSCs. Feeder layers provide a source of extracellular matrix (ECM) 12 
proteins and growth factors such as vitronectin, transforming growth factor  (TGF-) 13 
and Laminin-511 that aid hPSC proliferation and self-renewal. In 1998, Thomson et 14 
al. employed a MEF feeder layer to support hPSC growth in a medium of 80% 15 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20% fetal bovine 16 
serum (FBS), 1mM glutamine, 0.1mM -mercaptoethanol and 1% nonessential amino 17 
acids (NEAA). However, the use of non-human (xeno) feeder layers and animal-18 
derived serum such as FBS represent a potential source of pathogens such as 19 
endogenous retroviruses and xeno epitopes such as nonhuman sialic acid, N-20 
glycolneuraminic acid (Neu5Gc)
11
. Factors such as Neu5Gc, a monosaccharide, can 21 
induce an immune response upon transplantation of hPSCs cultured using xenogenic 22 
methods and limit their use to in vitro applications. 23 
 24 
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 1 
 2 
Feeder-free hPSC culture  3 
 4 
To produce hPSCs that are safer and more useful in clinical applications, feeder-free 5 
culture systems have been developed. The need to replace feeder layers with 6 
alternative growth substrates has driven a huge research effort in the discovery of 7 
materials that support the long-term self-renewal of hPSCs. Initial work on feeder-free 8 
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systems in 2001 employed animal-derived growth substrates such as Matrigel in 1 
combination with a MEF-conditioned medium (MEF-CM)
10
. Matrigel is harvested 2 
from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells and consists of a complex 3 
mixture of various extracellular matrix (ECM) proteins, proteoglycans and growth 4 
factors
12
. Unfortunately, culture systems consisting of undefined growth substrates 5 
like Matrigel and MEF-CM exhibit batch-to-batch variability. These elements within 6 
a culture system make understanding and controlling the cell-material interface 7 
difficult, a prerequisite to developing a scalable and reproducible hPSC culture 8 
system. Furthermore, batches of Matrigel have been contaminated with lactate 9 
dehydrogenase-elevating virus (LDV). This highlights safety concerns with xenogenic 10 
media components, although this particular pathogenic risk can be avoided with the 11 
use of Geltrex, an undefined LDV-free growth substrate (Table 2)
11, 13-24
. Although, 12 
Matrigel can now also be purchased LDV-free.  13 
Concerns over xenobiotic contamination have prompted the development and use of 14 
serum-free media in combination with growth substrates containing recombinant 15 
proteins
25
. In 2004, Amit et. al. successfully demonstrated the self-renewal of I3, I6 16 
and H9 hPSC lines on a fibronectin matrix using a serum replacement consisting of 17 
various growth factors known to play a role in maintenance of  pluripotency. Basic 18 
fibroblast growth factor (bFGF), transforming growth factor 1 (TGF1) and 19 
leukaemia inhibitory factor (LIF) were tested in different mixtures. A combination of 20 
TGF1 and bFGF with and without LIF was able to maintain pluripotency and retain 21 
normal hPSC features on a human fibronectin growth substrate. However, growth 22 
rates and cloning efficiencies of all combinations were inferior to MEF controls.  23 
 24 
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 2 
A major milestone in hPSC culture was the development of a defined culture medium 3 
called TeSR1 published in 2006
17
.  The essential ingredients within the TeSR1 4 
medium were the proteins basic fibroblast growth factor (bFGF) and transforming 5 
growth factor beta (TGF) , Lithium Chloride, -aminobutyric acid (GABA) and 6 
pipecolic acid. Cell lines H1 and H9 were both shown to self-renew for more than 10 7 
passages on a xeno-free growth substrate consisting of human collagen IV, 8 
fibronectin, laminin and vitronectin. The derivation of two new hPSC lines, WA15 9 
and WA16, was also achieved using TeSR1. However, WA15 became trisomic (three 10 
7 
 
chromosomes as opposed to two) for chromosome 12 between 4 and 7 months in 1 
culture. A variant of the TeSR1 culture cocktail has been commercialized as mTeSR1, 2 
employing BSA and zebrafish bFGF, for a cheaper alternative to the xeno-free culture 3 
medium. To further aid hPSC culture, supplements such as Rho-associated kinase 4 
(ROCK) inhibitors have been employed to reduce dissociation-induced cell apoptosis 5 
when working in defined medium
26
. However the impact of these inhibitors and their 6 
long-term effects on hPSCs are yet to be understood.  7 
 8 
High throughput screening has been used to discover small molecules that improve 9 
hPSC survival and self-renewal, to improve hPSC culture methodology. In 2010 Xu et 10 
al. published a high throughput chemical screen of 50,000 synthetic compounds to 11 
identify small molecules added to the culture media that promoted hPSC survival after 12 
trypsin dissociation from a Matrigel substrate
27
. Thiazovivin (Tzv) and Pyrintegrin 13 
(Ptn) were both found to dramatically increase cell survival versus DMSO controls. 14 
High throughput screening of small molecules can rapidly identify essential 15 
ingredients within current culture media employed in hPSC culture and be used to 16 
reduce the number of components within the hPSC culture system (Box 1)
26-40
. 17 
Furthermore, this screening approach can identify novel culture medium supplements 18 
to aid the survival and self-renewal of hPSCs in defined culture conditions. 19 
 20 
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 1 
 2 
Protein-based growth substrates 3 
 4 
Following the identification of mixtures of ECM proteins as adsorbates required for 5 
hPSC growth and self-renewal, effort was focused on identifying which proteins are 6 
most effective with specific media. Miyazaki et al. identified the laminins (LN)-111, -7 
332 and -511 as successful substrates for hPSC culture when used in combination 8 
with MEF-CM
41
. The hPSC lines KhES-1 and KhES-3 were found to express 9 
pluripotency markers after 10 passages and showed equal growth on LN-332 10 
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compared to Matrigel at 72 hours.  The utility of these substrates was attributed to 1 
their high affinity for the α6β1 integrin expressed on hPSCs. More recently, analogues 2 
of these substrates employing laminin E8 fragments (functionally minimal forms of 3 
laminin that can bind the α6β1 integrin) have been shown to support hPSC self-4 
renewal in defined xeno-free medium for 10 passages
42
. Laminin-332E8 and -511E8 5 
surfaces were able to support the self-renewal of H9, HES3, KhES-1 (hESC lines) and 6 
iPS(IMR90)-1, 253G1 (iPSC lines) in mTeSR1 and StemPro medium. Furthermore, 7 
all cell lines displayed normal karyotype at passage 10. These simplified laminin 8 
substrates were demonstrated to be successful for hPSC expansion at larger scale, 9 
such as T-75 tissue culture polystyrene flasks.  10 
 In a similar study, Rodin et al. demonstrated the long-term growth of hPSCs on LN-11 
511 coated plates for 20 passages over 4 months in chemically defined O3 medium 12 
and xeno-free H3 medium (both variants of TeSR1)
43
. Furthermore, cells were able to 13 
attach and migrate over/across the LN-511 coating creating continuous cell 14 
monolayers due to their affinity for the α6β1 integrin. This phenomenon was thought 15 
to have aided the long-term self-renewal of the hPSCs. However, passaging the cells 16 
required physical removal as clumps from the LN-511 coated plates rather than as 17 
single-cell suspensions. This method of passaging is compatible with automation and 18 
limits the scalability of this culture system. 19 
 20 
Peptide-based growth substrates 21 
 22 
Following the use of substrates coated with protein and protein fragments to promote 23 
hPSC adhesion, simplified substrates presenting specific peptide sequences have been 24 
developed to identify specific interactions at the cell-material interface that mediate 25 
10 
 
stem cell behaviour. Microarrays of laminin fragments were presented via self-1 
assembled monolayers (SAMs) by spotting 18 thiol functionalized peptides onto gold 2 
slides to rapidly identify cell-binding potential
44
. H1 and H9 cells that attached and 3 
proliferated after 6 days on certain laminin sequences displayed pluripotency markers 4 
at similar levels to Matrigel controls. However, scale up from micro array spots and 5 
expansion and long-term self-renewal on these surfaces was not demonstrated. 6 
Furthermore, the MEF-CM used to culture the hPSC makes this a complex and ill-7 
defined system which will contain many proteins and other biomolecules in the media 8 
solution and adsorbed to the surface.  9 
 10 
Carboxylate-containing acrylate monomers immobilized on plasma treated 11 
polystyrene plates, and subsequently conjugated to various RGD-containing short 12 
peptide sequences through the N-terminus, have been used to generate peptide-13 
acrylate surfaces (PAS)
45
. Of the six peptides employed, only two, bone sialoprotein 14 
(BSP) and VN-derived peptide, supported hPSC attachment, suggesting that RGD 15 
alone is a necessary but not sufficient binding motif. BSP- and VN-PAS were able to 16 
demonstrate long-term self-renewal (>10 passages) and were scalable to 75 cm
2
 17 
flasks. High surface density of the supportive peptide was required to achieve growth 18 
rates similar to Matrigel, with concentrations of BSP ranging from 0.75 - 1mM 19 
yielding 6 – 9 pmol/mm2 peptide density. VN-PAS coated flasks seeded with hPSCs 20 
and cultured for 4 days in defined medium showed uniform cell distributions, typical 21 
morphology and expressed the pluripotency marker OCT4.  This substrate has been 22 
developed commercially and marketed as Synthemax (Table 2)
13
, however, the 23 
biological components used in this substrate means that it is expensive (ca. $100/T75 24 
flask) compared to the widely used laboratory growth substrate Matrigel (ca. $15/T75 25 
11 
 
flask). Another example of a growth substrate that has been commercially developed 1 
is StemAdhere
14
. This growth substrate employs a fusion protein of the IgG Fc 2 
domain and E-cadherin, a Ca
2+
 dependent cell-cell adhesion molecule, which is 3 
coated onto polystyrene plates. This substrate was able to support long-term culture of 4 
H9 cells (90 passages) in mTeSR1 medium. Similarly to Synthemax, the recombinant 5 
nature of StemAdhere increases the expense of using these substrates significantly. 6 
The materials cost alone to produce 1 billion hPSCs (an approximation for a single 7 
patient intervention) is estimated to be ca. $10,000 and $15,000 for Synthemax and 8 
StemAdhere respectively (Table 3). This cost is likely to be prohibitive for cell 9 
expansion for clinical and biomedical use and is considerably greater than that using 10 
Matrigel, which is estimated to be ca. $1,500 (excluding the cost of cells and media) 11 
to produce 1 billion hPSCs. Phase 1 trials have been passed by regulators using 12 
Matrigel as an expansion substrate, but the exact meaning of GMP is still evolving for 13 
hPSC technologies and as more defined systems become available they are likely to 14 
be insisted upon.  15 
 16 
12 
 
1 
a
Scalability determined by the ability to synthesize the material in large quantity for 2 
manufacturing scale hPSC production in a cost-effective and timely manner, 
b
 3 
estimated using 100 x coated T75 flasks required to achieve 1 billion hPSCs, 
c
  4 
estimated by 150 kits required to coat a sufficient number of 6 well plates to achieve 1 5 
billion hPSCs, 
d
 estimated to be at least as expensive as a similar recombinant protein-6 
based substrate such as StemAdhere, 
e
 estimated by the cost of commercial monomers 7 
of ca. $0.5/g and 50mg of dissolved polymer required to coat 350 T75 flasks, 
f
 8 
estimated by the cost of 350 T75 flasks. 9 
 10 
Polymer-based growth substrates 11 
 12 
Systems that we classify as scalable are those which can be used to produce billions 13 
of cells in an economical and safe manner for many patients. For example, the 14 
material cost of producing 1 billion hPSCs using a Matrigel coated substrate is ca. 15 
13 
 
$1,500, far cheaper than Synthemax and StemAdhere (Table 2). A benchmark in the 1 
pharmaceutical industry to screen differentiated stem cells for drugs is to achieve a 2 
cost of <$1 per well (in a 96 well plate). This is not currently achievable for 3 
pluripotent stem cell culture. The peptide-polymer derived substrates mentioned 4 
previously are amenable to commercial development but ideally the substrate should 5 
be fully synthetic using readily synthesized and cheap monomers.  6 
Synthetic substrates that are polymer-based are generally inexpensive to manufacture 7 
and have shown broad utility commercially. Brafman et. al. employed a polymer 8 
microarray consisting of 91 commercially available and pre-synthesized polymers to 9 
screen for hPSC attachment in StemPro medium
46
. A broad range of polymer 10 
backbones and side chain functionalities were screened, including styrenes, acrylates 11 
and acrylamides spotted onto acrylamide coated glass slides.  Of the initial hits 12 
identified by high OCT4 and NANOG expression using fluorescence microscopy to 13 
identify pluripotency, one polymer, poly(methyl vinyl ether-alt-maleic anhydride) 14 
(Figure 1d(ii)), was able to support hPSC attachment and self-renewal for  >5 15 
passages using StemPro medium. Scalable expansion of hPSCs on this polymeric 16 
substrate was not demonstrated beyond cell expansion on polymer-coated slides.  17 
 18 
Six unique acrylate-based surfaces have also been prepared via an ozone-activation of 19 
tissue culture polystyrene (TCPS) and subsequent surface-initiated polymerization 20 
with a range of acrylate monomers
47
. One of these materials, poly [2-21 
(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] 22 
(PMEDSAH), was able to support the long-term culture of hPSC in serum-free 23 
defined mTeSR1 medium (including protein supplement) (Figure 1d(iii)). H9 cells 24 
were supported through 10 passages using StemPro medium, showed normal 25 
14 
 
karyotype and expressed similar levels of pluripotency markers to cells cultured on 1 
Matrigel. However, no scalability was demonstrated using this substrate material. 2 
Irwin et. al. developed a methacrylamide based coating (Figure 1d(iv)) which was 3 
grafted to TCPS dishes using a photoinitiated addition polymerization
48
. H1 and H9-4 
hOCT-pGZ hPSC lines were cultured in mTeSR1 medium for 10 passages, 5 
maintained typical cell morphology and grew in colonies similar to Matrigel cultured 6 
cells. Bovine serum albumin (BSA) was proposed to play a crucial role in hPSC 7 
attachment achieved in the culture medium. Quartz crystal microbalance with 8 
dissipation (QCM-D) experiments were used to identify BSA adsorption to the 9 
growth substrate from the mTeSR1 medium.  10 
 11 
 12 
Figure 1 | The development of hPSC growth substrates. (a) Feeder layers of MEFs 13 
to support cell adhesion and to condition the culture medium with ECM proteins to 14 
facilitate hPSC self-renewal. (b) Surface coating with an undefined ECM protein-15 
containing mixture, e.g. Matrigel. (c) Functional epitopes of ECM components 16 
immobilized to the surface to encourage hPSC attachment and self-renewal. (d) 17 
Polymeric growth substrates to provide an environment to adsorb essential ECM 18 
proteins from culture medium. 19 
 20 
 21 
 22 
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High throughput materials discovery for stem cell culture 1 
 2 
The defined growth substrates for adherent hPSC culture surveyed above have 3 
limitations, and consequently the search for new materials for hPSC culture continues. 4 
As we lack mechanistic understanding why cells respond to materials and media, high 5 
throughput methodologies have been employed to screen as wide a combinatorial 6 
chemical space as possible for materials supporting pluripotent cell number 7 
expansion.  8 
Surface modification strategies such as self-assembly have been used to present 9 
molecules capable of binding to cell surface integrins with high spatial resolution 10 
(Derda et al.
44
).  Arrays of peptide-substituted alkanethiols have been prepared as 11 
self-assembled monolayers on gold surfaces
49
. The molecules screened included 12 
peptides containing RGD and glycosaminoglycan binding epitopes, the most 13 
successful of which being a heparin-binding peptide derived from vitronectin (VN) 14 
(GKKQRFRHRNRKG). This peptide was able to support long-term self-renewal of 15 
hPSCs at peptide densities of 0.5-25% (% peptide-substituted alkane thiol in mixed 16 
SAM monolayer) when combined with ROCK inhibitor or cyclic RGD peptide. This 17 
peptide was used to functionalize glass and gold coated slides. Furthermore, 18 
biotinylated-GKKQRFRHRNRKG was used to functionalize steptavidin-coated 19 
TCPS dishes in a facile manner to reduce the cost of employing this peptide. 20 
However, hPSC expansion was not demonstrated over large areas, e.g. a culture flask. 21 
Pre-synthesized polymer libraries were printed as microarrays by Anderson et al.
50
 22 
employing the concept of combinatorial polymer libraries pioneered by Kohn et al in 23 
1997
51
. For high throughput materials discovery, this has the limitation that polymer 24 
synthesis is time consuming, reducing the diversity of such arrays and slowing the 25 
16 
 
follow up of leads generated on subsequent arrays. Ideally, the evolution from the 1 
initial screen to future generation arrays arises from hypotheses being formed from a 2 
first generation array that are subsequently tested in generations that evolve rapidly 3 
according to the results generated. On-slide synthesis of polymer microarrays was 4 
achieved by Anderson et al. in 2004
52
, allowing rapid synthesis of acrylate polymers 5 
by combinatorial mixing of liquid monomers printed onto a hydrogel coated slide 6 
prior to UV photoinitiated free radical polymerization. A strength of polymer 7 
microarrays is the ability to rapidly assess cell response to a large polymer library, 8 
which when coupled with the ability to perform surface analysis of the library on the 9 
array, allows cell-material surface interactions to be investigated rapidly
3
. 10 
 11 
Subsequently, several groups have used polymer microarrays to screen surface 12 
chemistries for hPSC attachment in a variety of culture media
46,52,54
. Mei et al. 13 
screened a number of generations of polymer microarray, starting with a library of 14 
496 unique materials formed by mixing 16 acrylate  ‘major’ monomers with 6 ‘minor’ 15 
monomers that were contact printed onto a poly(2-hydroxyethyl methacrylate) 16 
(pHEMA) coated substrate and polymerized in-situ using UV irradiation
53
. Polymers 17 
with potential as supports for pluripotent stem cells were identified by their ability to 18 
support the clonal growth of BG01-Oct4-GFP
+
 cells from very low initial seeding 19 
densities over 7 days in MEF-CM (arrays pre-conditioned with FBS). High content 20 
fluorescent microscopy was used to quantify cell response to the individual polymer 21 
spots using OCT4 GFP. High throughput surface characterization of the microarray 22 
was used to quantify the materials chemistry and properties such as wettability and 23 
indentation elastic modulus, which were subsequently compared to cell performance 24 
to identify the controlling surface factors. Colony-formation efficiency, a measure of 25 
17 
 
the number of colonies formed at day 7 from the initial low cell attachment on day 1, 1 
was used to quantify the performance of the hit substrates pre-adsorbed with ECM 2 
proteins. Human vitronectin pre-adsorbed surfaces gave the highest colony formation 3 
efficiency in mTESR1 medium maintaining pluripotency for 10 passages over 8 4 
weeks on microarrays comprising the hit materials (monomer 9 and 15A), however, 5 
only medium-term passaging (>5 passages over 1 month) was reported on surfaces 6 
pre-incubated with human serum albumin (HSA) and no scalability beyond 7 
microarray spots was demonstrated for the hit materials (Figure 1d (v)).   8 
A subsequent study used UV-ozone modification of polystyrene which maintained 9 
pluripotency for >10 passages on surfaces conditioned with HSA or human Vn in 10 
mTESR1 medium
54
. This growth substrate represents an attractive, cost-effective and 11 
simple route amenable to scale up, although Vn is still required as a pre-adsorption 12 
step for both approaches, which increases the cost of employing this culture system 13 
(Figure 1d (i)). 14 
More recently, Zhang et al. produced a microarray of 609 different thermoresponsive 15 
polymers by ink-jet printing 18 acrylate and acrylamide monomers with a crosslinker 16 
in various ratios
55
. The best performing material, an acrylate copolymer consisting of 17 
trimethylammonium chloride and diethylamino side-groups (HG21), supported the 18 
long-term self-renewal of RH1 cells (hPSC line) in mTeSR1 medium (>20 passages). 19 
Karyotype analysis of the RH1 cells at passage 21 found chromosomal abnormalities. 20 
This highlights the need for characterization of hPSCs at high passage number as 21 
abnormalities can occur after several passages which render the hPSCs unusable for 22 
clinical application.  23 
The thermoresponsive nature of the copolymer hydrogel permitted cellular 24 
detachment by reducing the culture medium temperature to 15
o
C for 30 minutes. This 25 
18 
 
step may be useful in automated stem cell expansion systems. Growth rates of RH1 1 
cells on hydrogel-coated coverslips were significantly lower than Matrigel controls; 2 
RH1 cells took 8-10 days to reach 80% confluence on the hydrogel coating as 3 
opposed 4-5 days on Matrigel in mTESR1 medium. Xeno-free culture medium was 4 
not used and scalability of this growth substrate was not demonstrated beyond coating 5 
of cover slips. The thermo switch of the gels was characterized by bulk rheology 6 
measurements of materials on cover slips. 7 
 8 
 9 
Mechanism of cell response to surface cues 10 
 11 
Many research groups have directed their efforts towards understanding the effect of 12 
materials on the regulation of stem cell behavior by designing substrates with 13 
particular chemistries, compliances, topographies, or containing biologically relevant 14 
moieties
49,56-57
.
  
Cell adhesion molecules that govern cell-matrix and cell-cell 15 
interactions play a crucial role in the long-term maintenance and self-renewal of 16 
adhered hPSCs.
 
The identification of cell surface integrins that can engage with 17 
Matrigel (β1) and Vitronectin (αvβ3 and αvβ5) -coated substrates has enabled an 18 
understanding of how hPSC pluripotency is maintained after they have adhered to 19 
substrates
42,53,58-59
. Cell-cell interactions mediated by cadherins and their role towards 20 
hPSC behavior has been extensively studied over recent years; see for example Li et 21 
al. for a recent review of this area
60
. Specifically, substrates presenting E-cadherin 22 
have been commercialized as StemAdhere and have proven to be useful substrates for 23 
hPSC expansion
14
.   24 
19 
 
Adsorption of individual proteins on polymeric substrates and the subsequent effect 1 
upon cellular performance has been well studied; see for example Koenig et al.
61 
and 2 
Weber et al.
62
. However, understanding which proteins adsorb from complex protein 3 
containing media onto materials, and the conformation they adopt on adsorption to a 4 
synthetic surface is still not yet possible, yet it is an essential element in gaining an 5 
understanding of material performance in protein containing culture conditions. Such 6 
knowledge will ultimately direct materials discovery towards improved substrates for 7 
hPSC culture. 8 
The topography and elastic modulus of synthetic substrates has been shown to 9 
influence the differentiation of stem cells
63-65
. These studies highlight the importance 10 
of physical as well as chemical properties in regulating self-renewal and 11 
differentiation in future culture systems used for large scale manufacture of hPSCs. 12 
Recently, the heparin-binding peptide GKKQRFRHRNRKG (see earlier discussion of 13 
this peptide) was attached to hydrogel-based surfaces of various moduli to enable 14 
mechanical control of hPSC self-renewal
67
. Immobilization of the peptide on the 15 
hydrogel substrates was achieved by a chemoselective reaction between maleimide 16 
moieties and the peptide terminated with a cysteine residue. Only stiff hydrogels (10 17 
kPa) were able to maintain hPSC pluripotency, which was facilitated by the activation 18 
of the Yes-Associated Protein (YAP) and transcriptional coactivator with PDZ-19 
binding motif (TAZ). The YAP/TAZ are implicated in hPSC pluripotency and the 20 
hydrogel exhibiting a Youngs Modulus of 10 kPa, determined by force indentation 21 
measurements using AFM, was most effective at inducing YAP/TAZ nuclear 22 
localization. 23 
 24 
 25 
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Modelling and Predicting Material Performance 1 
 2 
To support experimental materials discovery, computational methods of predicting the 3 
role of materials in encouraging cellular attachment have been explored
68 
(Figure 2). 4 
An early example of this was demonstrated for fibroblasts by Brocchini et al. who 5 
identified polymer-cell response relationships within a combinatorial library of pre-6 
synthesized copolymers spotted to form a micro array
69
. Linear correlations were 7 
observed between fibroblast proliferation and polymer surface hydrophobicity for a 8 
subset of the library of polymers. More recently human embryoid body cell adhesion 9 
to a library of polymers has been linked to molecular descriptors indicating that 10 
computational approached may be used to guide the design of materials production 11 
for experimentation with stem cells (Figure 2).
70 
  12 
 13 
Figure 2 | High throughput materials discovery. (a) Concept:  The small 14 
experimental material design space that can readily be accessed limits the discovery 15 
of new materials for hPSC culture. Directed materials discovery can be achieved 16 
through advanced modelling methods that enable structure-property relationships 17 
(SPRs) to be developed. This has the potential to allow access to materials design 18 
space yet to be explored experimentally. (b) Workflow (i) High throughput sample 19 
formats such as polymer microarrays can be screened for new growth substrates for 20 
21 
 
hPSC culture to access a small proportion of the potential chemical space. (ii) High 1 
throughput surface characterization can be employed in parallel to the biological 2 
assay. Correlation of the surface analytical data with cell performance using 3 
multivariate partial least-squares (PLS) regression links structure to function. Neural 4 
networks can identify molecular descriptors correlating with cell response. (iii) The 5 
predictive models have the potential to identify material chemistries that could not 6 
have been predicted from the experimental data alone. (iv) These advanced modelling 7 
techniques can be used to develop SPRs that can be used to explore new materials 8 
design space. This process can be performed in an iterative manner until an optimized 9 
material has been found. 10 
 11 
Surface chemical measurements can be used to determine the surface chemistries 12 
controlling cell attachment to materials with the aid of statistical and machine learning 13 
methods employed to aid interpretation of the large data sets.  For example, Chilkoti 14 
et al. characterized 15 oxygen-containing plasma-deposited films using static 15 
secondary ion mass spectrometry (SIMS)
71
.  A correlation between the positive and 16 
negative ion spectra from the materials and endothelial cell growth was determined 17 
using multivariate partial least-squares (PLS) regression. The PLS model identified 18 
ions within the SIMS spectra that contributed towards high and low cell attachment.  19 
Using a related approach, Urquhart et al. employed a combination of high throughput 20 
surface characterization (surface mass spectral data) and multivariate analysis (MVA) 21 
to predict the wettability of 576 polymers in a combinatorial microarray library
72-73
. A 22 
statistically valid PLS model between water contact angle (WCA) measurements and 23 
spectra obtained using time-of-flight secondary ion mass spectrometry (ToF-SIMS) 24 
was obtained. This study demonstrated the utility of MVA techniques such as PLS to 25 
22 
 
model datasets containing a large number of variables such as ToF-SIMS spectra 1 
(each with hundreds of secondary ions) of a polymer microarray (containing hundreds 2 
of materials). Following this, Mei et al. employed PLS regression to explore the 3 
relationship between surface chemistry of a combinatorial polymer microarray and the 4 
colony-formation frequency of hPSCs
53
. Good agreement between the measured 5 
colony-formation frequency and that predicted from the ToF-SIMS spectra from the 6 
material surfaces was found, highlighting the importance of surface chemistry of a 7 
material. The approach also helped identify the controlling surface functionalities, to 8 
allow improvements from one generation to the next, to obtain the best performing 9 
materials from the library of monomers available.  The lead polymers were pre-10 
adsorbed with vitronectin before cell seeding. To investigate the role of this step, 11 
ToF-SIMS of these protein conditioned polymer surfaces was used to analyze the 12 
chemistry of this surface. Strong correlations between cell attachment and protein 13 
fragment secondary ions were identified, indicating the synergy existing between the 14 
material surface chemistry and the identity and amount of the adsorbed proteins to 15 
enable colony-formation.  It is known from blocking experiments that the role of 16 
protein adsorption to polymeric growth substrates is pivotal to facilitate hPSC 17 
attachment and self-renewal via engagement with cell surface integrins
53
. 18 
Understanding which proteins adsorb from complex protein containing media to 19 
materials and their conformation is an essential component in interpreting material 20 
performance in protein containing culture conditions and will ultimately lead 21 
materials discovery towards better substrates for hPSC culture (Box 2). Although, at 22 
this time, unequivocal identification of protein identity and conformation from 23 
complex protein containing media is not possible.  24 
 25 
23 
 
1 
  2 
24 
 
Outlook 1 
 2 
Human pluripotent stem cells (hPSCs) have present possibilities in a wide variety of 3 
applications such as regenerative medicine and pharmaceutical drug screening. In the 4 
future, stem cell factories will be required to produce the large numbers of hPSC that 5 
will be required to meet the demand for billions of cells typical of regenerative 6 
medicine interventions currently in clinical trials. The long-term expansion and self-7 
renewal of hPSCs in xeno- and defined conditions is a prerequisite to achieving this. 8 
Xeno- and feeder-free E8 medium has now been commercialized
21
 and E6, a medium 9 
used to reprogram somatic cells to hiPSCs prior to expansion in E8, is currently under 10 
development.  For adherent hPSC culture this will also need to be supported by 11 
chemically defined substrates that offer high growth rates in a reproducible manner. 12 
Suspension hPSC culture has been shown as a promising alternative to adherent hPSC 13 
culture. However, refinement of the culture media components and improved growth 14 
rates versus adherent systems will need to be demonstrated before suspension culture 15 
can be considered as a viable alternative.  16 
 17 
The most recently developed defined substrates are polymers and peptides that are 18 
applicable to a xeno- and serum-free environment but few are able to support the 19 
expansion of hPSCs at levels similar to that of the current gold standard (but 20 
undefined) growth substrates, such as Matrigel. A number of novel polymers show 21 
promise, but still largely require protein pre-adsorption or display significant 22 
limitations in industrial scale up-mainly cost.  23 
 24 
25 
 
The search for new materials for adherent hPSC culture has been greatly accelerated 1 
by the recent application of high throughput sample screening strategies such as 2 
polymer microarrays. Surface characterization and correlative and predictive models 3 
make this a powerful approach with which to search for new materials. Development 4 
of quantitative structure-property relationships (SPRs) using the results from large 5 
experimental libraries linking polymer structure to hPSC performance on materials 6 
are likely to broaden the chemical combinatorial space beyond what is currently 7 
explored to facilitate the search for better materials for hPSC culture. The materials 8 
discovery process can be further aided through combination with high throughput 9 
screening of synthetic soluble factors that can replace biologically derived ingredients 10 
within hPSC culture media and increase the scalability of such culture systems.  11 
 12 
High throughput materials screening is moving towards the ability to carry out 13 
directed high throughput materials discovery to allow exploration beyond the existing 14 
experimentally investigated chemical space utilizing experimentally determined 15 
surface structure-property relationships (sSPRs) and computationally determined 16 
molecular descriptors. This will represent a step change in materials discovery 17 
capabilities to enable these discovery methods to evolve beyond the constraints of the 18 
current experimentally accessible chemical space. Recently, molecular descriptors 19 
have been used to predict the response of stem cell attachment and generate sSPRs in 20 
silicio, without the need for experimentally determined polymer characteristics
70
. 21 
Although the "reverse SPR" problem (backing out a polymer structure from an SPR 22 
model) has been challenging in the past, exciting new developments in mathematics 23 
have recently provided practical methods for designing polymers with optimal 24 
properties from structure-property relationships and molecular descriptors
74
. Success 25 
26 
 
in this endeavor would open up the full range of materials to computational 1 
examination to direct synthesis efforts to potentially fruitful areas for experimental 2 
exploration. We anticipate that these and the other material discovery approaches 3 
covered in this review will provide the new materials necessary for the stem cell 4 
factories of the future required to supply emerging stem cell therapies. 5 
 6 
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